Ugo Corrà Selected Research

Clostridium perfringens epsilon-toxin

1/2022	Cardiopulmonary exercise testing in patients with asymptomatic left ventricular dysfunction: lack of prognostic predictive power of ventilatory variables.
1/2022	Prognostic value of 6-min walk test compared to cardiopulmonary exercise test in patients with severe heart failure.
10/2021	Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up.
10/2020	Cardiopulmonary exercise testing in chronic heart failure patients treated with beta-blockers: Still a valid prognostic tool.
1/2018	Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology.
10/2016	Cardiopulmonary exercise testing in systolic heart failure: from basic to advanced practice.
1/2016	Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias.
9/2014	Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role: a position paper from the committee on exercise physiology and training of the heart failure association of the ESC.
9/2013	Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis.
4/2012	A new cardiopulmonary exercise testing prognosticating algorithm for heart failure patients treated with beta-blockers.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ugo Corrà Research Topics

Disease

49	Heart Failure 01/2022 - 09/2002
13	Cardiovascular Diseases (Cardiovascular Disease) 04/2022 - 03/2002
4	Left Ventricular Dysfunction 01/2022 - 03/2006
4	Myocardial Infarction 06/2017 - 02/2010
3	Coronary Artery Disease (Coronary Atherosclerosis) 11/2020 - 02/2010
2	Heart Diseases (Heart Disease) 12/2021 - 01/2021
2	Syncope (Fainting) 12/2021 - 01/2021
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 12/2021 - 01/2021
2	Cardiac Arrhythmias (Arrythmia) 12/2021 - 01/2021
2	Dyspnea (Shortness of Breath) 01/2021 - 08/2003
2	Atrial Fibrillation 01/2015 - 01/2015
2	Muscular Diseases (Myopathy) 09/2003 - 09/2002
1	COVID-19 10/2021
1	Disease Susceptibility (Diathesis) 04/2021
1	Death (Near-Death Experience) 10/2020
1	Diabetes Mellitus 10/2020
1	Frailty 01/2017
1	Musculoskeletal Diseases (Musculoskeletal Disease) 10/2016
1	Systolic Heart Failure 01/2015
1	Mitochondrial Myopathies (Mitochondrial Myopathy) 01/2012
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2012
1	Ventricular Remodeling 08/2008

Drug/Important Bio-Agent (IBA)

14	Clostridium perfringens epsilon-toxinIBA 01/2022 - 04/2006
5	Oxygen (Dioxygen)IBA 01/2021 - 03/2006
4	Carbon DioxideIBA 01/2020 - 03/2002
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 11/2007
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 01/2015
2	Carvedilol (Coreg)FDA LinkGeneric 12/2009 - 03/2004
1	DiureticsIBA 04/2021
1	Uric Acid (Urate)IBA 01/2020
1	Mineralocorticoid Receptor AntagonistsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 06/2016
1	Angiopoietin-2IBA 06/2016
1	SodiumIBA 01/2016
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 07/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	beta-Aminoethyl Isothiourea (AET)IBA 09/2013

Therapy/Procedure

13	Cardiac Rehabilitation 04/2022 - 08/2005
11	Therapeutics 04/2021 - 09/2002
10	Heart Transplantation (Grafting, Heart) 04/2021 - 03/2002
8	Secondary Prevention 04/2020 - 02/2010
7	Heart-Assist Devices 01/2019 - 03/2011
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 12/2021 - 01/2021
1	Length of Stay 04/2022
1	Activities of Daily Living (ADL) 01/2021
1	Glycemic Control 10/2020
1	Exercise Therapy (Therapy, Exercise) 01/2017
1	Telerehabilitation 10/2016
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 08/2008
1	Cardiac Resynchronization Therapy 06/2008
1	Patient Readmission 08/2003